Psychiatric Care for Incarcerated Patients
According to one review, there are more individuals with serious mental illness in correctional institutions than in all US state hospitals.
Year In Review Schizophrenia
Efficacy of Lurasidone Assessed in Adolescents With Schizophrenia
Sunovion have announced positive results from a study evaluating Latuda (lurasidone HCI) for the treatment of schizophrenia in adolescents aged 13 to 17 years old.
Prediabetic Markers May Be Linked With First-Episode Psychosis
The findings might help to explain the increased prevalence of type 2 diabetes in patients with schizophrenia.
Significant Cognitive Impairment in Those At High Risk of Psychosis
Studying cognition deficits during the clinical high risk period allows researchers to observe cognitive defects before chronicity and long-term medication use obscure the core deficits.
Study Elucidates Role of DIXDC1 Gene in Psychiatric Pathogenesis
Dixdc1 knockout mice demonstrated behaviors suggestive of depression, anxiety, and impaired social behavior.
Gene Expression Patterns in Polygenic Schizophrenia Risk
Data indicate that 693 genes are differentially expressed between individuals diagnosed with schizophrenia and typical, healthy controls.
Neuroinflammation in Schizophrenia: New PET Brain Imaging Studies
TSPO expression is frequently used as a biomarker for brain inflammation during PET imaging.
A Potential Biomarker for the Onset of Psychosis in High-risk Individuals
Researchers used the auditory mismatch negativity (MMN) paradigm to evaluate its potential as a neurophysiological biomarker for psychosis.
Poorly Organized Fiber Tracts in Patients With Schizophrenia
Investigators examined the white matter tracts in patients diagnosed with the schizophrenia with predominantly negative symptoms.
How Reliable Are Patient-reported Outcomes in Schizophrenia?
The primary outcome in this study was reliability of patient-ratings on subjective well-being.
Next post in Schizophrenia and Psychoses
